Anti-coronavirus disease 2019 (COVID-19) targets and mechanisms of puerarin.
Anti-coronavirus disease 2019 (COVID-19) targets and mechanisms of puerarin.
复制标题
葛根素抗2019冠状病毒病(COVID-19)的靶点和机制
DOI:
10.1111/jcmm.16117
复制
发表时间:
2021-01
影响因子:
5.3
通讯作者:
Li R
中科院分区:
文献类型:
--
作者:
Qin X;Huang C;Wu K;Li Y;Liang X;Su M;Li R
The present study aimed to uncover the pharmacological function and underlying mechanism of puerarin as a potential treatment for COVID‐19, using an in silico methodology, including network pharmacology and molecular docking. The pivotal targets of puerarin to treat COVID‐19 were identified and included the epidermal growth factor receptor (EGFR), tumour necrosis factor (TNF), tumour protein p53 (TP53), caspase 3 (CASP3), RELA proto‐oncogene (RELA), Fos proto‐oncogene (FOS), caspase 8 (CASP8), prostaglandin‐endoperoxide synthase 2 (PTGS2), interleukin 2 (IL2), protein kinase CB (PRKCB), B cell lymphoma/leukaemia gene‐2 (BCL2), protein kinase CA (PRKCA), nitric oxide synthase 3 (NOS3) and peroxisome proliferator–activated receptor gamma (PPARG). Functionally, the anti–COVID‐19 action of puerarin was associated with the suppression of oxidative stress and inflammatory cascades, and cell apoptosis. The signalling pathways of puerarin to treat COVID‐19 included modulation of the pathways of apoptosis, IL‐17 signalling, mitogen‐activated protein kinase (MAPK) signalling and TNF signalling. Molecular docking data illustrated the binding capacity of puerarin with COVID‐19 and the effective anti–COVID‐19 activity of puerarin. Taken together, our current network pharmacology–based findings revealed the pharmacological role of puerarin in the treatment of COVID‐19. Furthermore, the bioinformatic findings elucidated that some of these pivotal targets might serve as potential molecular markers for detecting COVID‐19.
登录
查看更多内容
影响因子:
2
作者:
Derda, Monika;Hadas, Edward;Thiem, Barbara
通讯作者:
Thiem, Barbara
影响因子:
9.5
作者:
Li, Rong;Wu, Ka;Chen, Jian
通讯作者:
Chen, Jian
影响因子:
4.3
作者:
Li, Rong;Xu, Lingyuan;Duan, Xiaoqun
通讯作者:
Duan, Xiaoqun
影响因子:
10.7
作者:
Wu, Ka;Wei, Pingyuan;Su, Min
通讯作者:
Su, Min
DOI:
10.18632/aging.103886
发表时间:
2020-10-08
期刊:
Aging
影响因子:
--
作者:
Nong Y;Liang Y;Liang X;Li Y;Yang B
通讯作者:
Yang B